Figure 1: Heparin catalysis of thrombin inhibition by antithrombin. Knowledge of the determinants of antithrombin specificity and the size requirement for bridging thrombin has led to the development ...
If you get a blood clot in your leg or another large blood vessel called a deep vein thrombosis (DVT), your treatment will include medications known as blood thinners. These drugs, also called ...
Health-Related Quality of Life in Non–Small-Cell Lung Cancer: An Update of a Systematic Review on Methodologic Issues in Randomized Controlled Trials Recent clinical research has focused on the ...
A pseudoaneurysm (also called a false aneurysm) is a collection of blood and blood clot that has formed outside a blood vessel, usually after an injury. The collection is connected by a channel to the ...
Thrombin [bovine origin] 5000 IU, 20000 IU; per vial; pwd for topical use after reconstitution; preservative-free. Thrombin-JMI requires no intermediate physiological agent for its action. It ...
After more than 70 years of effective clinical use, heparin remains the most common anticoagulant in use and one of the most commonly prescribed drugs to hospitalized patients. However, the biologic ...
In a study published in Advanced Materials, a research team developed an innovative bacterial cellulose (BC)-based hemostatic dressing that enables rapid and sustained bleeding control. Burn injuries ...
Sanofi’s Qfitlia and Cablivi approved in China, expanding care for rare diseasesQfitlia, the first antithrombin-lowering therapy for hemophilia, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback